Literature DB >> 181193

Lithium treatment during alcoholic withdrawal.

E M Sellers, S D Cooper, D H Zilm, C Shanks.   

Abstract

The efficacy of lithium carbonate was studied in 18 chronic alcoholic male patients in withdrawal. In mild alcoholic withdrawal, oral lithium carbonate, 0.3 gm every 8 hr, diminishes subjective symptoms of withdrawal and normalizes performance on a motor tracking task. Patients who start lithium while drinking ethanol improve most probably because it takes longer than 3 days for lithium concentrations in the blood to plateau. Lithium does not importantly alter patterns of catecholamine excretion, blood pressures, heart rate, serum cyclic-adenosine monophosphate (AMP), serum dopamine beta-hydroxylase (DBH), sleep pattern, or tremor amplitude during withdrawal.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 181193     DOI: 10.1002/cpt1976202199

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  3 in total

1.  Lithium effects on adjunctive alcohol consumption in rats.

Authors:  G Hines; D F Henslee
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 2.  Review of clinically important drug interactions with lithium.

Authors:  N S Harvey; S Merriman
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

3.  [Influence of lithium and rubidium on exploratory behaviour and locomotor activity in isolated male mice (author's transl)].

Authors:  M L Weischer
Journal:  Psychopharmacology (Berl)       Date:  1979-03-28       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.